tyrphostin ag 1024 has been researched along with Liver Neoplasms in 1 studies
tyrphostin AG 1024: modulates radiosensitivity in human breast cancer cells; also an IGF1 receptor inhibitor
Liver Neoplasms: Tumors or cancer of the LIVER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In contrast, p53 mutated Huh-7 hepatocellular cancer cells proved to be less sensitive towards cetuximab, but when combined with TKIs or fluvastatin or doxorubicin a pronounced reduction of cell growth was observed." | 1.33 | EGFR blockade by cetuximab alone or as combination therapy for growth control of hepatocellular cancer. ( Baradari, V; Höpfner, M; Huether, A; Scherübl, H; Schuppan, D, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huether, A | 1 |
| Höpfner, M | 1 |
| Baradari, V | 1 |
| Schuppan, D | 1 |
| Scherübl, H | 1 |
1 other study available for tyrphostin ag 1024 and Liver Neoplasms
| Article | Year |
|---|---|
EGFR blockade by cetuximab alone or as combination therapy for growth control of hepatocellular cancer.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Apoptosis; Cell Cy | 2005 |